Alzheimer's Disease
Genetics Consortium

ADGC Publications

Found 3 results

Filters: Keyword is Apolipoprotein E2 [Clear All Filters]

2022

Heath L, Earls JC, Magis AT, Kornilov SA, Lovejoy JC, Funk CC, Rappaport N, Logsdon BA, Mangravite LM, Kunkle BW et al.. 2022. Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90.. Sci Rep. 12(1):6117.

Jun GR, You Y, Zhu C, Meng G, Chung J, Panitch R, Hu J, Xia W, Bennett DA, Foroud TM et al.. 2022. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.. Alzheimers Dement. 18(11):2042-2054.

2010

Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R. 2010. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.. Am J Alzheimers Dis Other Demen. 25(3):233-8.